Comparison of Ocular Characteristic Between Major Thalassemia and Healthy Group

To determine and compare ocular characteristics and refractive errors between major thalassemia patients and normal subjects. In this study, 71 thalassemia major patients and 79 age and sex-matched healthy subjects that were selected in an ongoing manner underwent complete optometric and ophthalmic examinations, including autorefraction, subjective refraction, fluorescein tear break-up time, and pachymetry after anthropometric measurements. The results showed that the mean UCVA was better in the control group versus the thalassemia group (P<0.001), while there was no difference in BCVA between the two groups (P=0.416). Moreover, the mean spherical equivalent was 0.38±0.13 D less in the thalassemia group compared to the control group (P=0.007), while corneal power (P<0.001) and cylinder power (P=0.001) were larger in thalassemia patients. The most common type of astigmatism was against the rule pattern in thalassemia patients and with the rule pattern in the control group (P<0.001). The mean tear break-up time was 11.35±6.43 in the thalassemia group and 14.63±5.79 in the control group (P=0.001), and the mean near the point of accommodation (NPA) (P=0.009) and near the point of convergence (NPC). (P=0.003) were significantly smaller in the thalassemia group compared to the control group. These patients suffer from a myopic shift due to exaggerated responses to changes in ocular growth, dry eye secondary to goblet cell loss, and a higher prevalence of vertical astigmatism due to eyelid laxity and pressure on the cornea. Therefore, regular ophthalmological evaluations are highly recommended in these patients.

[1]  Beta Thalassemia , 2020, Definitions.

[2]  H. Hashemi,et al.  The distribution of near point of convergence in an Iranian rural population: A population-based cross-sectional study , 2019, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[3]  E. Jafarzadehpour,et al.  Comparison of contrast sensitivity in β-thalassemia patients treated by deferoxamine or deferasirox , 2018, Journal of optometry.

[4]  A. A. El-Shazly,et al.  Relation of anthropometric measurements to ocular biometric changes and refractive error in children with thalassemia , 2018, European journal of ophthalmology.

[5]  H. Hashemi,et al.  The prevalence of color vision deficiency in the northeast of Iran , 2017, Journal of current ophthalmology.

[6]  A. Liaska,et al.  β-Thalassemia and ocular implications: a systematic review , 2016, BMC Ophthalmology.

[7]  R. Jafari,et al.  Refractive errors and ocular biometry components in thalassemia major patients , 2016, International Ophthalmology.

[8]  R. Jafari,et al.  Ocular abnormalities in multi-transfused beta-thalassemia patients , 2015, Indian journal of ophthalmology.

[9]  G. Ozdemir,et al.  Ocular findings in children with thalassemia major in Eastern Mediterranean. , 2014, International journal of ophthalmology.

[10]  M. Nowroozzadeh,et al.  Ocular refractive and biometric characteristics in patients with thalassaemia major , 2011, Clinical & experimental optometry.

[11]  F. Trachtenberg,et al.  Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America , 2009, British journal of haematology.

[12]  F. Ghodsi,et al.  ASSESSING THE REFRACTIVE ERRORS IN BETA-THALASSEMIA MAJOR PATIENTS , 2009 .

[13]  M. Repanti,et al.  Study of the eye and lacrimal glands in experimental iron overload in rats in vivo , 2008, Anatomical science international.

[14]  M. Radfar,et al.  Thalassemia in Iran: Epidemiology, Prevention, and Management , 2007, Journal of pediatric hematology/oncology.

[15]  P. Perissutti,et al.  Congenital Growth Hormone Deficiency and Eye Refraction: A Longitudinal Study , 2005, Ophthalmologica.

[16]  E. Terpos,et al.  New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia , 2004, British journal of haematology.

[17]  P. Perissutti,et al.  Refractive evaluation in children with growth defect , 2004, Current eye research.

[18]  S. Laradi,et al.  Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[19]  S. Gartaganis,et al.  Alterations in Conjunctival Cytology and Tear Film Dysfunction in Patients with &bgr;-Thalassemia , 2003, Cornea.

[20]  M. Bekheirnia,et al.  Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran , 2003, BMC endocrine disorders.

[21]  S. Schrier Pathophysiology of the thalassemias. The Albion Walter Hewlett Award presentation. , 1997, The Western journal of medicine.

[22]  H. Pearson,et al.  PATHOPHYSIOLOGY OF THALASSEMIAS , 1974, Annals of the New York Academy of Sciences.

[23]  M. Bandyopadhyay,et al.  A Study to Assess the Ocular Biometric Parameters and Prevalence of Refractive Errors among Thalassemic Children in a Rural Based Tertiary Hospital , 2017 .

[24]  K. Saad,et al.  Growth Parameters and Vitamin D status in Children with Thalassemia Major in Upper Egypt , 2013, International journal of hematology-oncology and stem cell research.

[25]  Pat Beckley Historical Perspectives , 2006 .